Transcenta Holding Limited, a global biotherapeutics company, has named Dr Charlie Qi as its new senior vice president of Global Clinical Development, it was reported on Monday.
Dr Qi has served in various pharmaceutical companies such as Roche, Hutchison MediPharma and Eli Lilly. Most recently, he served as the head of Oncology Product Development at Roche Global Product Development Center in Shanghai.
Dr Li Xu, acting chief medical officer, stated: "We are pleased and honoured to have Dr Qi join the Transcenta team. Dr Qi brings Transcenta with his extensive experience in clinical development of innovate drugs in China. He will lead clinical development of new drugs in our pipeline in China."
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer